Butabarbital (CRM) (Item No. 20088) is a certified reference material categorized as a barbiturate. It has a high abuse potential and increases risk of overdose morbidity and mortality in recreational drug users. Butabarbital is regulated as a Schedule III compound in the United States. Butabarbital (CRM) (Item No. 20088) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
Controlled substance (depressant). Sedative, hypnotic.
Butabarbital is also used as a soporific drug in various forms of insomnia and as a sedative. The most frequently used synonym is butizone.
ChEBI: Butabarbital is a member of barbiturates.
Butabarb (Alpharma);
Butalan (Lannett); Buticaps (Medpointe); Butisol Sodium
(Medpointe); Sarisol (Halsey).
Butabarbital, 5-ethyl-5-isobutylbarbituric acid (4.1.11), is also synthesized
in an analogous manner by condensation of |á-ethyl-|á-isobutylmalonic ester with urea [9].
